Global Health Data Exchange - Discover the World's Health Data

Susceptibility of Plasmodium Falciparum to Antimalarial Drugs: Report on Global Monitoring 1996-2004

Nav

General Info
Provider 
World Health Organization (WHO)
Tabulations only
Geography 
Afghanistan (AFG)
Bangladesh (BGD)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Botswana (BWA)
Burkina Faso (BFA)
Burundi (BDI)
Cambodia (KHM)
Cameroon (CMR)
Central African Republic (CAF)
Chad (TCD)
Colombia (COL)
Comoros (COM)
Congo (COG)
Côte d'Ivoire (CIV)
Democratic Republic of the Congo (COD)
Ecuador (ECU)
Equatorial Guinea (GNQ)
Eritrea (ERI)
Ethiopia (ETH)
Gabon (GAB)
Ghana (GHA)
Guinea (GIN)
Guinea-Bissau (GNB)
Guyana (GUY)
India (IND)
Indonesia (IDN)
Iran (Islamic Republic of) (IRN)
Kenya (KEN)
Lao People's Democratic Republic (LAO)
Liberia (LBR)
Madagascar (MDG)
Mali (MLI)
Mauritania (MRT)
Mozambique (MOZ)
Myanmar (MMR)
Namibia (NAM)
Niger (NER)
Nigeria (NGA)
Pakistan (PAK)
Papua New Guinea (PNG)
Peru (PER)
Philippines (PHL)
Rwanda (RWA)
Sao Tome and Principe (STP)
Saudi Arabia (SAU)
Senegal (SEN)
Sierra Leone (SLE)
Solomon Islands (SLB)
Somalia (SOM)
South Africa (ZAF)
Sudan (SDN)
Suriname (SUR)
Eswatini (SWZ)
Tajikistan (TJK)
United Republic of Tanzania (TZA)
Thailand (THA)
Gambia (GMB)
Timor-Leste (TLS)
Togo (TGO)
Uganda (UGA)
Vanuatu (VUT)
Venezuela (Bolivarian Republic of) (VEN)
Viet Nam (VNM)
Zambia (ZMB)
Zanzibar (United Republic of Tanzania)
Zimbabwe (ZWE)
View all
Coverage type 
Global
Time period covered 
01/1996 - 12/2004
Data type
Report:
  • Epi surveillance
Summary 

The Susceptibility of Plasmodium Falciparum to Antimalarial Drugs: Report on Global Monitoring 1996-2004 presents an overview of antimalarial drug efficacy for more than 60 countries during 1996-2004. The report also discusses drug efficacy monitoring criteria and how therapeutic efficacy tests can help inform national malaria treatment policies. Data in the report come from the WHO global antimalarial drug efficacy database, which collects data from three main sources: published data obtained from other databases, unpublished data obtained from reports by ministries of health and other governmental organizations, and raw data from surveillance studies conducted following WHO Guidelines. The report includes figures with treatment failure and success rates aggregated by WHO region and subregion. An annex with a summary of results for the efficacy of antimalarial drugs is also included. 

Keywords 
Antimalarials, Health care access, Health care economics, Malaria, Therapies
GHDx Entry last modified on: Sep 23, 2022